Evaluating the Efficacy of Tocilizumab in Moderate to Severe COVID-19 with Progressive Illness despite Steroids: Identifying the Optimal Timing of Its Administration in C3G Study
Background: High mortality has been described in coronavirus disease 2019 (COVID-19

